Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atracurium versus succinylcholine for anesthesia support during electroconvulsive therapy
IRCT20170314033069N2Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Oct 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of atracurium, succinylcholine, propofol, neostigmine and atropine in mental disorder (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Heart rate, Blood pressure and 2 more. Started Oct 2020; status: completed.
02
Drugs
atracuriumsuccinylcholinepropofolneostigmineatropine
03
Conditions
mental disorder
Beyond the preview
Go deeper on IRCT20170314033069N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170314033069N2.